英国国家卒中临床指南2023版要点及解读——缺血性卒中

Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland(Edition 2023)—Ischemic Stroke

缺血性卒中的急性期治疗一直是备受关注的话题。英国国家卒中临床指南2016版推出7年来,急性缺血性卒中患者的再灌注已经有了很大的治疗进展以及研究突破,基于这些进展,英国国家卒中临床指南2023版在2016版的基础上,对缺血性卒中的急性期治疗方案进行了部分推荐意见的更新。本文对2023版指南的更新要点进行解读,并与2019年出版的美国心脏学会/美国卒中学会急性缺血性卒中早期管理指南及2023年出版的《中国脑血管病临床管理指南(第2版)》中的推荐进行了对比。

The treatment of ischemic stroke in acute phase has always been a highly discussed topic.In the seven years since the publication of the 2016 edition of the national clinical guideline for stroke for the United Kingdom and Ireland,there have been significant developments in reperfusion therapy for acute ischemic stroke patients.The 2023 edition of the guidelines updated some recommendations on the acute phase treatment of ischemic stroke based on the 2016 edition.This paper will provide an interpretation of the key update points in the 2023 edition and compare them with the 2019 American Heart Association(AHA)/American Stroke Association(ASA)guidelines for the early management of patients with acute ischemic stroke,and The Chinese Clinical Management Guidelines for Cerebrovascular Diseases(2nd Edition)published in 2023.